Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO TrialFrancesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Clinical Cardiology|March 26, 2019
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trialPatricia O Guimarães, Sean D Pokorney, Renato D Lopes, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACSConnie N Hess, Phillip J Schulte, L Kristin Newby, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a reviewAlexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
The New England Journal of Medicine|November 17, 2020
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisAllan L Klein, Massimo Imazio, Paul Cremer, et al.
American Heart Journal|September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trialEmmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
Heart (British Cardiac Society)|October 31, 2022
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditisAntonio Brucato, Alistair Wheeler, Sushil Allen Luis, et al.
The Lancet. Neurology|May 11, 2012
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trialJ Donald Easton, Renato D Lopes, M Cecilia Bahit, et al.
International Journal of Cardiology|November 7, 2013
Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trialMaria Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
JACC. Heart Failure|June 27, 2024
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA TrialMuhammad Shahzeb Khan, Javed Butler, Rebecca Young, et al.
Pageof 22